Andrew J. Wang

Array ( [id] => 3915551 [patent_doc_number] => 06001991 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-12-14 [patent_title] => 'Antisense oligonucleotide modulation of MDR P-glycoprotein gene expression' [patent_app_type] => 1 [patent_app_number] => 8/940250 [patent_app_country] => US [patent_app_date] => 1997-09-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 12720 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 57 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/001/06001991.pdf [firstpage_image] =>[orig_patent_app_number] => 940250 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4032939 [patent_doc_number] => 05942419 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-08-24 [patent_title] => 'RsbW-1 encoding nucleic acids' [patent_app_type] => 1 [patent_app_number] => 8/938717 [patent_app_country] => US [patent_app_date] => 1997-09-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 15010 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 34 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/942/05942419.pdf [firstpage_image] =>[orig_patent_app_number] => 938717 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4271954 [patent_doc_number] => 06307040 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-10-23 [patent_title] => 'Sugar modified oligonucleotides that detect and modulate gene expression' [patent_app_type] => 1 [patent_app_number] => 8/936166 [patent_app_country] => US [patent_app_date] => 1997-09-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 18913 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 18 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/307/06307040.pdf [firstpage_image] =>[orig_patent_app_number] => 936166 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3808234 [patent_doc_number] => 05831033 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-11-03 [patent_title] => 'Human thymosin .beta.15 gene, protein and uses thereof' [patent_app_type] => 1 [patent_app_number] => 8/931877 [patent_app_country] => US [patent_app_date] => 1997-09-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 21 [patent_no_of_words] => 11565 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 19 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/831/05831033.pdf [firstpage_image] =>[orig_patent_app_number] => 931877 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3785230 [patent_doc_number] => 05840562 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-11-24 [patent_title] => 'DNA encoding human cysteine protease' [patent_app_type] => 1 [patent_app_number] => 8/928613 [patent_app_country] => US [patent_app_date] => 1997-09-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 13895 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 26 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/840/05840562.pdf [firstpage_image] =>[orig_patent_app_number] => 928613 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4045816 [patent_doc_number] => 05874567 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-02-23 [patent_title] => 'Therapeutic oligonucleotides targeting the human MDR1 and MRP genes' [patent_app_type] => 1 [patent_app_number] => 8/927561 [patent_app_country] => US [patent_app_date] => 1997-09-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 17697 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 82 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/874/05874567.pdf [firstpage_image] =>[orig_patent_app_number] => 927561 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3810958 [patent_doc_number] => 05811520 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-09-22 [patent_title] => 'Human phospholipase inhibitor protein' [patent_app_type] => 1 [patent_app_number] => 8/919706 [patent_app_country] => US [patent_app_date] => 1997-08-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 22 [patent_figures_cnt] => 22 [patent_no_of_words] => 18173 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/811/05811520.pdf [firstpage_image] =>[orig_patent_app_number] => 919706 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4062294 [patent_doc_number] => 06007991 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-12-28 [patent_title] => 'Antisense oligonucleotides for mitogen-activated protein kinases as therapy for cancer' [patent_app_type] => 1 [patent_app_number] => 8/909742 [patent_app_country] => US [patent_app_date] => 1997-08-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 18 [patent_no_of_words] => 10778 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 45 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/007/06007991.pdf [firstpage_image] =>[orig_patent_app_number] => 909742 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4008398 [patent_doc_number] => 05888983 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-03-30 [patent_title] => 'Method and oligonucleobase compounds for curing diseases caused by mutations' [patent_app_type] => 1 [patent_app_number] => 8/906265 [patent_app_country] => US [patent_app_date] => 1997-08-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 17260 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 125 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/888/05888983.pdf [firstpage_image] =>[orig_patent_app_number] => 906265 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3775136 [patent_doc_number] => 05808001 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-09-15 [patent_title] => 'Human ice homolog antibodies and compositions thereof' [patent_app_type] => 1 [patent_app_number] => 8/900491 [patent_app_country] => US [patent_app_date] => 1997-07-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 10428 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 23 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/808/05808001.pdf [firstpage_image] =>[orig_patent_app_number] => 900491 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3784814 [patent_doc_number] => 05840537 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-11-24 [patent_title] => 'cDNA encoding a vesicle transport protein' [patent_app_type] => 1 [patent_app_number] => 8/900927 [patent_app_country] => US [patent_app_date] => 1997-07-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 19768 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 13 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/840/05840537.pdf [firstpage_image] =>[orig_patent_app_number] => 900927 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4180528 [patent_doc_number] => 06020192 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-02-01 [patent_title] => 'Humanized green fluorescent protein genes and methods' [patent_app_type] => 1 [patent_app_number] => 8/893327 [patent_app_country] => US [patent_app_date] => 1997-07-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 22 [patent_figures_cnt] => 29 [patent_no_of_words] => 39171 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 14 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/020/06020192.pdf [firstpage_image] =>[orig_patent_app_number] => 893327 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3932625 [patent_doc_number] => 05972607 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-10-26 [patent_title] => 'Methods for nucleic acid amplification with thermostable ribonuclease H' [patent_app_type] => 1 [patent_app_number] => 8/893023 [patent_app_country] => US [patent_app_date] => 1997-07-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 9 [patent_no_of_words] => 9460 [patent_no_of_claims] => 46 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 98 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/972/05972607.pdf [firstpage_image] =>[orig_patent_app_number] => 893023 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3771962 [patent_doc_number] => 05773580 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-06-30 [patent_title] => 'Human protein kinase c inhibitor homolog' [patent_app_type] => 1 [patent_app_number] => 8/892692 [patent_app_country] => US [patent_app_date] => 1997-07-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 17646 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/773/05773580.pdf [firstpage_image] =>[orig_patent_app_number] => 892692 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3999475 [patent_doc_number] => 05922844 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-07-13 [patent_title] => 'Human cAMP-dependent protein kinase inhibitor homolog' [patent_app_type] => 1 [patent_app_number] => 8/892150 [patent_app_country] => US [patent_app_date] => 1997-07-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 16591 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/922/05922844.pdf [firstpage_image] =>[orig_patent_app_number] => 892150 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3969030 [patent_doc_number] => 05886150 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-03-23 [patent_title] => 'Peptides capable of binding to the GAP protein SH3 domain, nucleotide sequences coding therefor, and preparation and use thereof' [patent_app_type] => 1 [patent_app_number] => 8/836791 [patent_app_country] => US [patent_app_date] => 1997-07-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 2 [patent_no_of_words] => 6561 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 54 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/886/05886150.pdf [firstpage_image] =>[orig_patent_app_number] => 836791 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3835344 [patent_doc_number] => 05846777 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-12-08 [patent_title] => 'Two cDNAs encoding WD-40 proteins' [patent_app_type] => 1 [patent_app_number] => 8/883534 [patent_app_country] => US [patent_app_date] => 1997-06-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 20927 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 13 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/846/05846777.pdf [firstpage_image] =>[orig_patent_app_number] => 883534 [rel_patent_id] =>[rel_patent_doc_number] =>)